![4-Morpholinecarboximidamide,N-[3-[(1S)-1-(2-fluoro[1,1'-biphenyl]-4-yl)ethyl]-5-isoxazolyl]-](https://static.cymitquimica.com/cas-image/394108-4-morpholinecarboximidamide-n-3-1s-1-2-fluoro-11-biphenyl-4-yl-ethyl-5-isoxazolyl.png)
CAS: 215174-50-8 - 4-Morpholinecarboximidamide,N-[3-[(1S)-1-(2-fluoro[1,1'-biphenyl]-4-yl)ethyl]-5-isoxazolyl]-
Formula:C22H23FN4O2
- Synonyms:
- Rimacalib
- Smp 114
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Rimacalib REF: TR-R505015CAS: 215174-50-8 | - - - | 275.00 €~1,819.00 € | Mon 03 Mar 25 |
| Rimacalib Morpholine D8 REF: TR-R505017CAS: 215174-50-8 | - - - | 13,286.00 € | Mon 03 Mar 25 |
 | Rimacalib REF: TM-T16752CAS: 215174-50-8 | 98% | To inquire | Tue 11 Mar 25 |
 | Rimacalib REF: 3D-FR177034CAS: 215174-50-8 | Min. 95% | - - - | Discontinued product |
Rimacalib
Controlled ProductCAS:215174-50-8
Formula:
C22H23FN4O2
Color and Shape:
Neat
Molecular weight:
394.45
Ref: TR-R505015
| 1mg | 275.00 € | ||
| 10mg | 1,819.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
Rimacalib Morpholine D8
Controlled ProductCAS:215174-50-8
Formula:
C22D8H15FN4O2
Color and Shape:
Neat
Molecular weight:
402.491
Ref: TR-R505017
| 50mg | 13,286.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
Rimacalib
CAS:215174-50-8
Rimacalib is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (IC50s: ~1 μM for CaMKIIα and …
Formula:
C22H23FN4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
394.44
Ref: TM-T16752
| 25mg | 1,410.00 € | ||
| 50mg | 1,845.00 € | ||
| 100mg | 2,329.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Rimacalib
CAS:215174-50-8
Rimacalib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the group of drugs known …
Formula:
C22H23FN4O2
Purity:
Min. 95%
Molecular weight:
394.44 g/mol
Ref: 3D-FR177034
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
